ATE437946T1 - Ribozyme mit breiter trna-aminoacylierungswirkung - Google Patents

Ribozyme mit breiter trna-aminoacylierungswirkung

Info

Publication number
ATE437946T1
ATE437946T1 AT03709182T AT03709182T ATE437946T1 AT E437946 T1 ATE437946 T1 AT E437946T1 AT 03709182 T AT03709182 T AT 03709182T AT 03709182 T AT03709182 T AT 03709182T AT E437946 T1 ATE437946 T1 AT E437946T1
Authority
AT
Austria
Prior art keywords
ribozymes
broad
action
aminoacylation
trna aminoacylation
Prior art date
Application number
AT03709182T
Other languages
English (en)
Inventor
Hiroaki Suga
Hiroshi Murakami
Hirohide Saito
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE437946T1 publication Critical patent/ATE437946T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03709182T 2002-02-15 2003-02-18 Ribozyme mit breiter trna-aminoacylierungswirkung ATE437946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35742402P 2002-02-15 2002-02-15
PCT/US2003/005007 WO2003070740A1 (en) 2002-02-15 2003-02-18 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY

Publications (1)

Publication Number Publication Date
ATE437946T1 true ATE437946T1 (de) 2009-08-15

Family

ID=27757615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709182T ATE437946T1 (de) 2002-02-15 2003-02-18 Ribozyme mit breiter trna-aminoacylierungswirkung

Country Status (8)

Country Link
US (1) US7622248B2 (de)
EP (1) EP1483282B1 (de)
JP (1) JP4464684B2 (de)
AT (1) ATE437946T1 (de)
AU (1) AU2003213136A1 (de)
CA (1) CA2476425C (de)
DE (1) DE60328587D1 (de)
WO (1) WO2003070740A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005319099B2 (en) 2004-02-02 2010-09-16 Ambrx, Inc. Modified human growth hormone
EP1951890A4 (de) 2005-11-16 2009-06-24 Ambrx Inc Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren
JP5119444B2 (ja) * 2005-12-06 2013-01-16 国立大学法人 東京大学 多目的アシル化触媒とその用途
EP2615108B1 (de) 2006-09-08 2016-10-26 Ambrx, Inc. Modifiziertes humanes Plasmapolypeptid oder Fc-Gerüste und deren Verwendungen
JP5200241B2 (ja) * 2006-11-17 2013-06-05 国立大学法人 東京大学 Ｎ末端に非天然骨格をもつポリペプチドの翻訳合成とその応用
US9090668B2 (en) * 2007-03-26 2015-07-28 The University Of Tokyo Process for synthesizing cyclic peptide compound
ATE554785T1 (de) 2007-03-30 2012-05-15 Ambrx Inc Modifizierte fgf-21 polypeptide und ihre verwendung
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
EP2930182A1 (de) 2007-11-20 2015-10-14 Ambrx, Inc. Modifizierte insulinpolypeptide und deren verwendungen
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
MX2011003196A (es) 2008-09-26 2011-04-27 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
EP2376647B1 (de) * 2009-01-12 2014-03-05 Sutro Biopharma, Inc. Mono-ladesystem zur selektiven einführung von nichtnativen aminosäuren in proteine anhand eines in-vitro-proteinsynthesesystems
BR112012015597A2 (pt) 2009-12-21 2017-01-31 Ambrx Inc peptídeos de somatotropina suínos modificados e seus usos
MX349301B (es) 2009-12-21 2017-07-21 Ambrx Inc Polipéptidos de somatotropina bovina modificados y sus usos.
HUE045845T2 (hu) 2010-08-17 2021-12-28 Ambrx Inc Módosított relaxin polipeptidek és felhasználásuk
JP5818237B2 (ja) * 2010-09-09 2015-11-18 国立大学法人 東京大学 Ｎ−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
US10195578B2 (en) 2010-12-03 2019-02-05 The University Of Tokyo Peptide library production method, peptide library, and screening method
EA036697B1 (ru) 2014-10-24 2020-12-09 Бристол-Майерс Сквибб Компани Модифицированные полипептиды fgf-21 и их применение
FI3849614T3 (fi) 2018-09-11 2024-02-08 Ambrx Inc Interleukiini-2-polypeptidikonjugaatteja ja niiden käyttöjä
JP2022512746A (ja) 2018-10-19 2022-02-07 アンブルックス，インコーポレイテッド インターロイキン－１０ポリペプチド複合体、その二量体、およびそれらの使用
BR112021015832A2 (pt) 2019-02-12 2022-01-18 Ambrx Inc Composições que contêm conjugados de anticorpo-agonista de tlr, métodos e usos dos mesmos
AU2021233909A1 (en) 2020-03-11 2022-09-29 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
AU2021327396A1 (en) 2020-08-20 2023-03-23 Ambrx, Inc. Antibody-TLR agonist conjugates, methods and uses thereof
WO2022212899A1 (en) 2021-04-03 2022-10-06 Ambrx, Inc. Anti-her2 antibody-drug conjugates and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084987C (en) 1990-06-11 2007-02-13 Larry Gold Nucleic acid ligands
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5998142A (en) 1993-09-08 1999-12-07 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US6063566A (en) 1994-05-13 2000-05-16 The Scripps Research Institute Catalytic RNA molecules
ES2127106B1 (es) 1996-03-21 1999-11-16 Menarini Lab Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
US5871924A (en) * 1997-01-27 1999-02-16 Nexstar Pharmaceuticals, Inc. Method for the production of ligands capable of facilitating aminoacyl-RNA synthesis
US6280936B1 (en) * 1997-06-09 2001-08-28 Ribozyme Pharmaceuticals, Inc. Method for screening nucleic acid catalysts
DE19801153A1 (de) * 1998-01-14 1999-07-15 Jenne Andreas Verfahren zur Selektion von Ribozymen, die Ribonucleinsäuren in trans an 2'-OH-Gruppen kovalent modifizieren können und durch dieses Verfahren erhältliche Ribozyme
WO2001038582A1 (en) * 1999-11-24 2001-05-31 The Research Foundation Of State University Of New York CATALYTIC RNAs WITH AMINOACYLATION ACTIVITY

Also Published As

Publication number Publication date
US20030228593A1 (en) 2003-12-11
EP1483282A4 (de) 2007-06-06
US7622248B2 (en) 2009-11-24
EP1483282A1 (de) 2004-12-08
AU2003213136A1 (en) 2003-09-09
JP4464684B2 (ja) 2010-05-19
EP1483282B1 (de) 2009-07-29
CA2476425C (en) 2012-04-17
WO2003070740A1 (en) 2003-08-28
DE60328587D1 (de) 2009-09-10
CA2476425A1 (en) 2003-08-28
JP2005528090A (ja) 2005-09-22

Similar Documents

Publication Publication Date Title
ATE437946T1 (de) Ribozyme mit breiter trna-aminoacylierungswirkung
Kayser et al. Spike-phase coding boosts and stabilizes information carried by spatial and temporal spike patterns
HUP0203704A2 (hu) L-Pankolakton hidroláz és eljárás D-pantolakton előállítására
AU6113200A (en) Conditional-selex
DK1106696T3 (da) Proteindeamiderende enzym, mikroorganisme producerende dette, gen kodende derfor, fremgangsmåde til fremstilling af enzymet og anvendelse deraf
BR0101847B1 (pt) tanque de combustÍvel e mÉtodo de produÇço do mesmo.
ATE363280T1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
BR0207314B1 (pt) piscina de onda e mÉtodo de criar méltiplas formaÇÕes de onda.
EP2385103A3 (de) Abweichender Hypocrea jecorina CBH1
DE60332820D1 (de) Verfahren und mittel zur überwachung und modulation des gen-silencing
DE69736598D1 (de) Ribonukleaseresistente rna präparation und seine verwendung
EA200500019A1 (ru) Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
DE69933653D1 (de) Ribozyme die fähig sind die expression des ccr5 rezeptor zu hemmen
BR0111584A (pt) Método para a produção de um produto alimentìcio comprendendo bactérias de lactobacilos não viáveis, e, produto alimentìcio
BR0102290B1 (pt) eletrodo para evoluÇço de gÁs e seu mÉtodo de produÇço.
WO2006023997A3 (en) Composition and method for tenderizing meat
DE60039120D1 (de) Katalytische rnas mit aminoacylierender aktivität
DE60139544D1 (de) Veränderte, fluoreszierende proteine
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
ATE309356T1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
IS7154A (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
BR0307463B1 (pt) aÇo inoxidÁvel martensÍtico e mÉtodo para fabricaÇço do mesmo.
AU2003235506A8 (en) Targeted enzymes and methods of making and using targeted enzymes.
DK0906443T3 (da) Generering af replikerende molekyler in vivo
DK1242602T3 (da) Proteinekspressionssystemer for ikke-patogene kinetoplastidae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties